Veterinary Dermatology Drugs Market , 2012 to 2023
Global Veterinary Dermatology Drugs Market:
Global veterinary dermatology drugs market is projected to expand at robust growth rate over the forecast period.
Veterinary profession has experienced a dramatic shift from the past few decades. Several demographic and socioeconomic factors have contributed to drastic changes, including livestock, food production, social attitudes, urbanization, increased adoption of companion animals are expected fuel the veterinary dermatology drugs market over the forecast period.
Atopic dermatitis is the common cause of itching in companion animals. Atopy is genetically determined predisposition to become allergic to airborne pollens such as weeds, grass, trees, house dust, and molds. In companion animals dogs, cats atopic dermatitis is most common cause of chewing, biting, rubbing as well as chronic skin and ear infections. Surge in the prevalence of chronic skin disorders anticipated to boost the market revenue size.
Increasing demand for farm animal and poultry sector is expected to boost the veterinary dermatology drugs market. Rising awareness regarding various dermatological disorders and treatment methods, favorable government initiatives in order to increase farm animal production are expected to create demand for veterinary dermatology drugs market in future.
Veterinary dermatology drugs market has been segmented on the basis of product, application, animal type, end user.
Based on product type, veterinary dermatology drugs market has been segmented into the following:
Antibiotics
NSAIDS
Veterinary antifungal drugs
Others
Based on animal type, veterinary dermatology drugs market has been segmented into the following:
Food Animal
Small Animal
Equine
Others
Based on end user, veterinary dermatology drugs market has been segmented into the following:
Veterinary hospitals
Veterinary clinics
Others
Animals are susceptible to numerous chronic skin disorders. Some skin tumours can be treated using medical therapy or cryotherapy. Skin disorders can be occurring by various agents such as allergens, burns, external irritants, trauma (Viral, bacterial, fungal, other parasitic).
Evolution of chronic skin diseases and increased mergers & acquisitions to offer better products are able to offer novel products to the market. Rising awareness among the pet lovers and increased health checkups are expected to create lucrative opportunities in the future.
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
U.S. veterinary dermatology drugs market is expected to dominate revenue share over the forecast period due to increased pet ownership and availability of adequate veterinary healthcare infrastructure have a profound positive impact on the market. For instance, 62% of US households are having a companion animal, equating to 72.9 million homes.
Germany veterinary dermatology drugs market is anticipated to grow at modest growth rate over the forecast period, increased awareness is creating demand for veterinary dermatology drugs market.
Emerging nations China, India, Brazil, Mexico, and Russia are witnessing higher rates of pet adoption due to demographics changes, rising disposable income are few factors.
China veterinary dermatology drugs market is expanding at significant growth rate, owing to rising companion animal adoption, and spending on veterinary healthcare are majorly driving the market.
Rising disposable income coupled with rising veterinary healthcare infrastructure are expected to accelerate the Indian veterinary dermatology drugs market size.
Middle East countries are majorly driven by increasing pet adoption coupled with rising veterinary spending.
Global Veterinary dermatology drugs market is dominated by key players such as Zoetis Inc., Elanco, Merial, Bayer Animal Health, Virbac S.A., IDEXX Laboratories, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, Vetoquinol S.A.
Global veterinary dermatology drugs market is projected to expand at robust growth rate over the forecast period.
Veterinary profession has experienced a dramatic shift from the past few decades. Several demographic and socioeconomic factors have contributed to drastic changes, including livestock, food production, social attitudes, urbanization, increased adoption of companion animals are expected fuel the veterinary dermatology drugs market over the forecast period.
Atopic dermatitis is the common cause of itching in companion animals. Atopy is genetically determined predisposition to become allergic to airborne pollens such as weeds, grass, trees, house dust, and molds. In companion animals dogs, cats atopic dermatitis is most common cause of chewing, biting, rubbing as well as chronic skin and ear infections. Surge in the prevalence of chronic skin disorders anticipated to boost the market revenue size.
Increasing demand for farm animal and poultry sector is expected to boost the veterinary dermatology drugs market. Rising awareness regarding various dermatological disorders and treatment methods, favorable government initiatives in order to increase farm animal production are expected to create demand for veterinary dermatology drugs market in future.
Veterinary dermatology drugs market has been segmented on the basis of product, application, animal type, end user.
Based on product type, veterinary dermatology drugs market has been segmented into the following:
Antibiotics
NSAIDS
Veterinary antifungal drugs
Others
Based on animal type, veterinary dermatology drugs market has been segmented into the following:
Food Animal
Small Animal
Equine
Others
Based on end user, veterinary dermatology drugs market has been segmented into the following:
Veterinary hospitals
Veterinary clinics
Others
Animals are susceptible to numerous chronic skin disorders. Some skin tumours can be treated using medical therapy or cryotherapy. Skin disorders can be occurring by various agents such as allergens, burns, external irritants, trauma (Viral, bacterial, fungal, other parasitic).
Evolution of chronic skin diseases and increased mergers & acquisitions to offer better products are able to offer novel products to the market. Rising awareness among the pet lovers and increased health checkups are expected to create lucrative opportunities in the future.
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
U.S. veterinary dermatology drugs market is expected to dominate revenue share over the forecast period due to increased pet ownership and availability of adequate veterinary healthcare infrastructure have a profound positive impact on the market. For instance, 62% of US households are having a companion animal, equating to 72.9 million homes.
Germany veterinary dermatology drugs market is anticipated to grow at modest growth rate over the forecast period, increased awareness is creating demand for veterinary dermatology drugs market.
Emerging nations China, India, Brazil, Mexico, and Russia are witnessing higher rates of pet adoption due to demographics changes, rising disposable income are few factors.
China veterinary dermatology drugs market is expanding at significant growth rate, owing to rising companion animal adoption, and spending on veterinary healthcare are majorly driving the market.
Rising disposable income coupled with rising veterinary healthcare infrastructure are expected to accelerate the Indian veterinary dermatology drugs market size.
Middle East countries are majorly driven by increasing pet adoption coupled with rising veterinary spending.
Global Veterinary dermatology drugs market is dominated by key players such as Zoetis Inc., Elanco, Merial, Bayer Animal Health, Virbac S.A., IDEXX Laboratories, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, Vetoquinol S.A.
1. EXECUTIVE SUMMARY
2. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET INTRODUCTION
2.1. Global Veterinary Dermatology Drugs Market – Taxonomy
2.2. Global Veterinary Dermatology Drugs Market –Definitions
2.2.1. Product Type
2.2.2. Animal Type
2.2.3. Distribution Channel
3. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Veterinary Dermatology Drugs Market Dynamic Factors - Impact Analysis
3.6. Global Veterinary Dermatology Drugs Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Veterinary Dermatology Drugs Market –Trends
4. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Antibiotics
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. NSAIDS
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Veterinary antifungal drugs
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET FORECAST, BY ANIMAL TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Animal Food Animal
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Small Animal
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Equine
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET FORECAST, BY DISTRIBUTION CHANNEL TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Veterinary Hospitals
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Veterinary Clinics
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. North America
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal, By Distribution Channel and Region, 2017 – 2023
9. NORTH AMERICA VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Antibiotics
9.1.2. NSAIDS
9.1.3. Veterinary antifungal drugs
9.1.4. Others
9.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Food Animal
9.2.2. Small Animal
9.2.3. Equine
9.2.4. Others
9.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Veterinary Hospitals
9.3.2. Veterinary Clinics
9.3.3. Others
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
9.6. North America Veterinary Dermatology Drugs Market Dynamics – Trends
10. EUROPE VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Antibiotics
10.1.2. NSAIDS
10.1.3. Veterinary antifungal drugs
10.1.4. Others
10.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Food Animal
10.2.2. Small Animal
10.2.3. Equine
10.2.4. Others
10.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Veterinary Hospitals
10.3.2. Veterinary Clinics
10.3.3. Others
10.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
10.6. Europe Veterinary Dermatology Drugs Market Dynamics – Trends
11. ASIA-PACIFIC VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Antibiotics
11.1.2. NSAIDS
11.1.3. Veterinary antifungal drugs
11.1.4. Others
11.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Food Animal
11.2.2. Small Animal
11.2.3. Equine
11.2.4. Others
11.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Veterinary Hospitals
11.3.2. Veterinary Clinics
11.3.3. Others
11.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
11.6. Asia-Pacific Veterinary Dermatology Drugs Market Dynamics – Trends
12. LATIN AMERICA VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Antibiotics
12.1.2. NSAIDS
12.1.3. Veterinary antifungal drugs
12.1.4. Others
12.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Food Animal
12.2.2. Small Animal
12.2.3. Equine
12.2.4. Others
12.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Veterinary Hospitals
12.3.2. Veterinary Clinics
12.3.3. Others
12.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
12.6. Latin America Veterinary Dermatology Drugs Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Antibiotics
13.1.2. NSAIDS
13.1.3. Veterinary antifungal drugs
13.1.4. Others
13.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Food Animal
13.2.2. Small Animal
13.2.3. Equine
13.2.4. Others
13.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Veterinary Hospitals
13.3.2. Veterinary Clinics
13.3.3. Others
13.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
13.6. MEA Veterinary Dermatology Drugs Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Zoetis Inc.
14.2.2. Elanco
14.2.3. Merial
14.2.4. Bayer Animal Health
14.2.5. Virbac S.A.
14.2.6. IDEXX Laboratories
14.2.7. Boehringer Ingelheim Vetmedica
14.2.8. Ceva Sante Animale
14.2.9. Vetoquinol S.A.
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET INTRODUCTION
2.1. Global Veterinary Dermatology Drugs Market – Taxonomy
2.2. Global Veterinary Dermatology Drugs Market –Definitions
2.2.1. Product Type
2.2.2. Animal Type
2.2.3. Distribution Channel
3. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Veterinary Dermatology Drugs Market Dynamic Factors - Impact Analysis
3.6. Global Veterinary Dermatology Drugs Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Veterinary Dermatology Drugs Market –Trends
4. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Antibiotics
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. NSAIDS
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Veterinary antifungal drugs
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET FORECAST, BY ANIMAL TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Animal Food Animal
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Small Animal
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Equine
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET FORECAST, BY DISTRIBUTION CHANNEL TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Veterinary Hospitals
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Veterinary Clinics
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL VETERINARY DERMATOLOGY DRUGS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. North America
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal, By Distribution Channel and Region, 2017 – 2023
9. NORTH AMERICA VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Antibiotics
9.1.2. NSAIDS
9.1.3. Veterinary antifungal drugs
9.1.4. Others
9.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Food Animal
9.2.2. Small Animal
9.2.3. Equine
9.2.4. Others
9.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Veterinary Hospitals
9.3.2. Veterinary Clinics
9.3.3. Others
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
9.6. North America Veterinary Dermatology Drugs Market Dynamics – Trends
10. EUROPE VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Antibiotics
10.1.2. NSAIDS
10.1.3. Veterinary antifungal drugs
10.1.4. Others
10.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Food Animal
10.2.2. Small Animal
10.2.3. Equine
10.2.4. Others
10.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Veterinary Hospitals
10.3.2. Veterinary Clinics
10.3.3. Others
10.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
10.6. Europe Veterinary Dermatology Drugs Market Dynamics – Trends
11. ASIA-PACIFIC VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Antibiotics
11.1.2. NSAIDS
11.1.3. Veterinary antifungal drugs
11.1.4. Others
11.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Food Animal
11.2.2. Small Animal
11.2.3. Equine
11.2.4. Others
11.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Veterinary Hospitals
11.3.2. Veterinary Clinics
11.3.3. Others
11.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
11.6. Asia-Pacific Veterinary Dermatology Drugs Market Dynamics – Trends
12. LATIN AMERICA VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Antibiotics
12.1.2. NSAIDS
12.1.3. Veterinary antifungal drugs
12.1.4. Others
12.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Food Animal
12.2.2. Small Animal
12.2.3. Equine
12.2.4. Others
12.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Veterinary Hospitals
12.3.2. Veterinary Clinics
12.3.3. Others
12.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
12.6. Latin America Veterinary Dermatology Drugs Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA VETERINARY DERMATOLOGY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Antibiotics
13.1.2. NSAIDS
13.1.3. Veterinary antifungal drugs
13.1.4. Others
13.2. Animal Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Food Animal
13.2.2. Small Animal
13.2.3. Equine
13.2.4. Others
13.3. Distribution Channel Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Veterinary Hospitals
13.3.2. Veterinary Clinics
13.3.3. Others
13.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Veterinary Dermatology Drugs Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Distribution Channel and Country, 2017 – 2023
13.6. MEA Veterinary Dermatology Drugs Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Zoetis Inc.
14.2.2. Elanco
14.2.3. Merial
14.2.4. Bayer Animal Health
14.2.5. Virbac S.A.
14.2.6. IDEXX Laboratories
14.2.7. Boehringer Ingelheim Vetmedica
14.2.8. Ceva Sante Animale
14.2.9. Vetoquinol S.A.
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
